Switch to:
Also traded in: Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 3/10

vs
industry
vs
history
Cash-to-Debt 0.02
NYSE:HCA's Cash-to-Debt is ranked lower than
95% of the 266 Companies
in the Global Medical Care industry.

( Industry Median: 0.48 vs. NYSE:HCA: 0.02 )
Ranked among companies with meaningful Cash-to-Debt only.
NYSE:HCA' s Cash-to-Debt Range Over the Past 10 Years
Min: 0  Med: 0.02 Max: N/A
Current: 0.02
Equity-to-Asset -0.21
NYSE:HCA's Equity-to-Asset is ranked lower than
97% of the 262 Companies
in the Global Medical Care industry.

( Industry Median: 0.48 vs. NYSE:HCA: -0.21 )
Ranked among companies with meaningful Equity-to-Asset only.
NYSE:HCA' s Equity-to-Asset Range Over the Past 10 Years
Min: -0.5  Med: 0.23 Max: 0.42
Current: -0.21
-0.5
0.42
Interest Coverage 3.60
NYSE:HCA's Interest Coverage is ranked lower than
74% of the 223 Companies
in the Global Medical Care industry.

( Industry Median: 8.41 vs. NYSE:HCA: 3.60 )
Ranked among companies with meaningful Interest Coverage only.
NYSE:HCA' s Interest Coverage Range Over the Past 10 Years
Min: 1.09  Med: 2.3 Max: 3.62
Current: 3.6
1.09
3.62
Piotroski F-Score: 6
Altman Z-Score: 2.19
Beneish M-Score: -2.95
WACC vs ROIC
3.38%
17.80%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 8/10

vs
industry
vs
history
Operating Margin % 14.70
NYSE:HCA's Operating Margin % is ranked higher than
73% of the 267 Companies
in the Global Medical Care industry.

( Industry Median: 7.39 vs. NYSE:HCA: 14.70 )
Ranked among companies with meaningful Operating Margin % only.
NYSE:HCA' s Operating Margin % Range Over the Past 10 Years
Min: 7.48  Med: 13.99 Max: 15.86
Current: 14.7
7.48
15.86
Net Margin % 6.82
NYSE:HCA's Net Margin % is ranked higher than
61% of the 268 Companies
in the Global Medical Care industry.

( Industry Median: 4.40 vs. NYSE:HCA: 6.82 )
Ranked among companies with meaningful Net Margin % only.
NYSE:HCA' s Net Margin % Range Over the Past 10 Years
Min: 2.37  Med: 4.71 Max: 8.3
Current: 6.82
2.37
8.3
ROA % 8.57
NYSE:HCA's ROA % is ranked higher than
78% of the 270 Companies
in the Global Medical Care industry.

( Industry Median: 3.85 vs. NYSE:HCA: 8.57 )
Ranked among companies with meaningful ROA % only.
NYSE:HCA' s ROA % Range Over the Past 10 Years
Min: 2.79  Med: 5.66 Max: 9.71
Current: 8.57
2.79
9.71
ROC (Joel Greenblatt) % 34.21
NYSE:HCA's ROC (Joel Greenblatt) % is ranked higher than
71% of the 270 Companies
in the Global Medical Care industry.

( Industry Median: 16.38 vs. NYSE:HCA: 34.21 )
Ranked among companies with meaningful ROC (Joel Greenblatt) % only.
NYSE:HCA' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: 21.49  Med: 30.35 Max: 37.66
Current: 34.21
21.49
37.66
3-Year Revenue Growth Rate 12.30
NYSE:HCA's 3-Year Revenue Growth Rate is ranked higher than
65% of the 193 Companies
in the Global Medical Care industry.

( Industry Median: 7.90 vs. NYSE:HCA: 12.30 )
Ranked among companies with meaningful 3-Year Revenue Growth Rate only.
NYSE:HCA' s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: -7.8  Med: 8.6 Max: 24.3
Current: 12.3
-7.8
24.3
3-Year EBITDA Growth Rate 14.80
NYSE:HCA's 3-Year EBITDA Growth Rate is ranked higher than
69% of the 170 Companies
in the Global Medical Care industry.

( Industry Median: 7.90 vs. NYSE:HCA: 14.80 )
Ranked among companies with meaningful 3-Year EBITDA Growth Rate only.
NYSE:HCA' s 3-Year EBITDA Growth Rate Range Over the Past 10 Years
Min: -10  Med: 8.6 Max: 39.4
Current: 14.8
-10
39.4
3-Year EPS without NRI Growth Rate 29.40
NYSE:HCA's 3-Year EPS without NRI Growth Rate is ranked higher than
82% of the 144 Companies
in the Global Medical Care industry.

( Industry Median: 7.90 vs. NYSE:HCA: 29.40 )
Ranked among companies with meaningful 3-Year EPS without NRI Growth Rate only.
NYSE:HCA' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: 0  Med: 12.7 Max: 88.4
Current: 29.4
0
88.4
GuruFocus has detected 3 Warning Signs with HCA Healthcare Inc $NYSE:HCA.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
» NYSE:HCA's 30-Y Financials

Financials (Next Earnings Date: 2017-08-02 Est.)


Revenue & Net Income
Cash & Debt
Operating Cash Flow & Free Cash Flow
Operating Cash Flow & Net Income

» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Health Care Providers » Medical Care    NAICS: 622110    SIC: 8062
Compare:NYSE:FMS, OTCPK:FSNUY, NYSE:DVA, OTCPK:IHHHF, NYSE:UHS, OTCPK:SKHCF, NAS:WOOF, NYSE:EVHC, OTCPK:NMHLY, OTCPK:CAKFY, NYSE:MD, NYSE:HLS, NAS:ACHC, NYSE:CHE, NAS:LPNT, OTCPK:LTGHY, NAS:AMED, NYSE:SEM, NYSE:THC, NYSE:AMN » details
Traded in other countries:2BH.Germany,
Headquarter Location:USA
HCA Healthcare Inc, formerly HCA Holdings Inc is a health care services company. It operates general acute care hospitals, psychiatric hospitals; and rehabilitation hospitals. It also operates freestanding surgery centers.

Accounting for about 5% of total U.S. hospital admissions, HCA is the largest private hospital owner and operator in the United States. It operates 170 hospitals and 118 outpatient centers, offering a broad range of health services. HCA has operations in 20 states and in England, but a majority of its operations are in the Southern United States, particularly in Florida and Texas. Outpatient services make up about 40% of HCA's patient revenue.

Guru Investment Theses on HCA Healthcare Inc

Bill Nygren Comments on HCA - Jan 10, 2017

HCA (NYSE:HCA) is the largest operator of for-profit hospitals and related health care services in the U.S. The company benefits from scale and size advantages, an attractive geographic footprint in higher growth markets, best-in-class management and governance, and an equity-friendly approach to capital allocation. We expect HCA to grow operating income in the mid-single digits and grow EPS in the low-double digits over time. Hospital stocks sold off following the presidential election due to concerns that the benefits from health care reform will be lost. We believe that HCA’s share price discounts the effects of repealing the Affordable Care Act. Accordingly, the shares are selling below our estimate of intrinsic value.

From Bill Nygren (Trades, Portfolio)'s Oakmark Fund fourth quarter 2016 commentary.

Check out Bill Nygren latest stock trades

Top Ranked Articles about HCA Healthcare Inc

Sharecare Closes New Investment, Brings Total Funding to More Than $300 Million
Bill Nygren Comments on HCA Guru stock highlight
HCA (NYSE:HCA) is the largest operator of for-profit hospitals and related health care services in the U.S. The company benefits from scale and size advantages, an attractive geographic footprint in higher growth markets, best-in-class management and governance, and an equity-friendly approach to capital allocation. We expect HCA to grow operating income in the mid-single digits and grow EPS in the low-double digits over time. Hospital stocks sold off following the presidential election due to concerns that the benefits from health care reform will be lost. We believe that HCA’s share price discounts the effects of repealing the Affordable Care Act. Accordingly, the shares are selling below our estimate of intrinsic value. Read more...
Michael Burry: Current Holdings and a Change of Style Burry's Scion Capital holdings have shrunk dramatically in recent months as the famous value investor takes money out of the market
Dr. Michael Burry is one of the financial world’s most closely followed hedge fund managers. He shot to fame last year after being portrayed in the movie “The Big Short,” which profiled his bet against the housing market in 2008. However, even in the run-up to the housing crisis, Burry was building his reputation as a respected value investor. His hedge fund, Scion Capital, was one of the best performing funds in the industry in the run-up to 2007. It was Burry’s ingenuity and attention to detail that helped the fund shoot to fame. Read more...
Glenn Greenberg Gains 3 Positions in the 3rd Quarter Guru invests in health care, technology and telecommunications
Brave Warrior Advisors’ Glenn Greenberg (Trades, Portfolio) purchased three new holdings in the third quarter. They are HCA Holdings Inc. (NYSE:HCA), Sensata Technologies Holding NV (NYSE:ST) and LiLAC Group (NASDAQ:LILAK). Read more...
Dr. Michael Burry of 'The Big Short' Buys Only One Stock as He Further Cuts Portfolio Investor who called the financial crisis keeps only three positions
Dr. Michael Burry, an investor best known for being portrayed in the movie “The Big Short,” but who became a legend for shorting the mortgage market in 2007, has continued his trend of making sweeping changes to and slimming down his portfolio each quarter at his reborn fund, Scion Asset Management. Read more...
David Tepper Exits Facebook, Boosts Allergan Guru's second quarter trades
David Tepper (Trades, Portfolio) is the founder of Appaloosa Management, which is a $3 billion hedge fund investment firm based in Chatham, New Jersey. The following are his largest trades of the second quarter. Read more...
The Big 3: Larry Robbins' Top 2nd-Quarter Buys Guru reports quarterly portfolio
Larry Robbins (Trades, Portfolio), founder of Glenview Capital Management, seeks capital appreciation through deep fundamental research on stocks with high growth potential. During the second quarter, Robbins made big purchases in three separate company stocks: IMS Health Holdings Inc. (NYSE:IMS), Williams Holdings Inc. (NYSE:WMB) and Quintiles Transnational Holdings Inc. (NYSE:Q). Read more...
Healthcare Growth Stocks in the S&P 500: Part 2 Weakness in the healthcare sector has created buying opportunities in 7 companies
Introduction Read more...
Healthcare Growth Stocks in the S&P 500: Part 2 Weakness in the healthcare sector has created buying opportunities with 7 companies
Introduction Read more...
John Hussman Buys Infosys, Southern The guru's largest 2nd-quarter acquisitions
John Hussman (Trades, Portfolio) is the president and principal shareholder of Hussman Strategic Advisors, the investment advisory firm that manages the Hussman Funds. During the second quarter he bought shares in the following stocks. Read more...

Ratios

vs
industry
vs
history
PE Ratio 11.79
HCA's PE Ratio is ranked higher than
89% of the 205 Companies
in the Global Medical Care industry.

( Industry Median: 26.08 vs. HCA: 11.79 )
Ranked among companies with meaningful PE Ratio only.
HCA' s PE Ratio Range Over the Past 10 Years
Min: 4.08  Med: 13.38 Max: 19.67
Current: 11.79
4.08
19.67
Forward PE Ratio 11.67
HCA's Forward PE Ratio is ranked higher than
92% of the 63 Companies
in the Global Medical Care industry.

( Industry Median: 21.14 vs. HCA: 11.67 )
Ranked among companies with meaningful Forward PE Ratio only.
N/A
PE Ratio without NRI 11.79
HCA's PE Ratio without NRI is ranked higher than
91% of the 202 Companies
in the Global Medical Care industry.

( Industry Median: 26.57 vs. HCA: 11.79 )
Ranked among companies with meaningful PE Ratio without NRI only.
HCA' s PE Ratio without NRI Range Over the Past 10 Years
Min: 4.08  Med: 13.38 Max: 19.67
Current: 11.79
4.08
19.67
Price-to-Owner-Earnings 11.86
HCA's Price-to-Owner-Earnings is ranked higher than
86% of the 107 Companies
in the Global Medical Care industry.

( Industry Median: 27.27 vs. HCA: 11.86 )
Ranked among companies with meaningful Price-to-Owner-Earnings only.
HCA' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 6.27  Med: 12.2 Max: 58.95
Current: 11.86
6.27
58.95
PS Ratio 0.81
HCA's PS Ratio is ranked higher than
79% of the 257 Companies
in the Global Medical Care industry.

( Industry Median: 1.71 vs. HCA: 0.81 )
Ranked among companies with meaningful PS Ratio only.
HCA' s PS Ratio Range Over the Past 10 Years
Min: 0.32  Med: 0.69 Max: 1.06
Current: 0.81
0.32
1.06
Price-to-Free-Cash-Flow 12.38
HCA's Price-to-Free-Cash-Flow is ranked higher than
82% of the 117 Companies
in the Global Medical Care industry.

( Industry Median: 24.29 vs. HCA: 12.38 )
Ranked among companies with meaningful Price-to-Free-Cash-Flow only.
HCA' s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 4.08  Med: 11.57 Max: 17.18
Current: 12.38
4.08
17.18
Price-to-Operating-Cash-Flow 6.08
HCA's Price-to-Operating-Cash-Flow is ranked higher than
89% of the 169 Companies
in the Global Medical Care industry.

( Industry Median: 15.22 vs. HCA: 6.08 )
Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.
HCA' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 2.57  Med: 5.78 Max: 8.48
Current: 6.08
2.57
8.48
EV-to-EBIT 9.89
HCA's EV-to-EBIT is ranked higher than
88% of the 215 Companies
in the Global Medical Care industry.

( Industry Median: 20.08 vs. HCA: 9.89 )
Ranked among companies with meaningful EV-to-EBIT only.
HCA' s EV-to-EBIT Range Over the Past 10 Years
Min: 6.3  Med: 10.6 Max: 12.6
Current: 9.89
6.3
12.6
EV-to-EBITDA 7.55
HCA's EV-to-EBITDA is ranked higher than
87% of the 227 Companies
in the Global Medical Care industry.

( Industry Median: 15.13 vs. HCA: 7.55 )
Ranked among companies with meaningful EV-to-EBITDA only.
HCA' s EV-to-EBITDA Range Over the Past 10 Years
Min: 5  Med: 7.8 Max: 9.4
Current: 7.55
5
9.4
PEG Ratio 1.38
HCA's PEG Ratio is ranked higher than
78% of the 99 Companies
in the Global Medical Care industry.

( Industry Median: 3.08 vs. HCA: 1.38 )
Ranked among companies with meaningful PEG Ratio only.
HCA' s PEG Ratio Range Over the Past 10 Years
Min: 0.6  Med: 2.1 Max: 5.73
Current: 1.38
0.6
5.73
Shiller PE Ratio 17.44
HCA's Shiller PE Ratio is ranked higher than
76% of the 51 Companies
in the Global Medical Care industry.

( Industry Median: 28.83 vs. HCA: 17.44 )
Ranked among companies with meaningful Shiller PE Ratio only.
HCA' s Shiller PE Ratio Range Over the Past 10 Years
Min: 6.17  Med: 13.56 Max: 23.08
Current: 17.44
6.17
23.08
Current Ratio 1.65
HCA's Current Ratio is ranked higher than
60% of the 267 Companies
in the Global Medical Care industry.

( Industry Median: 1.32 vs. HCA: 1.65 )
Ranked among companies with meaningful Current Ratio only.
HCA' s Current Ratio Range Over the Past 10 Years
Min: 0.81  Med: 1.51 Max: 2.25
Current: 1.65
0.81
2.25
Quick Ratio 1.38
HCA's Quick Ratio is ranked higher than
55% of the 267 Companies
in the Global Medical Care industry.

( Industry Median: 1.25 vs. HCA: 1.38 )
Ranked among companies with meaningful Quick Ratio only.
HCA' s Quick Ratio Range Over the Past 10 Years
Min: 0.71  Med: 1.35 Max: 2.12
Current: 1.38
0.71
2.12
Days Inventory 77.03
HCA's Days Inventory is ranked lower than
88% of the 202 Companies
in the Global Medical Care industry.

( Industry Median: 15.65 vs. HCA: 77.03 )
Ranked among companies with meaningful Days Inventory only.
HCA' s Days Inventory Range Over the Past 10 Years
Min: 57.16  Med: 68.53 Max: 77.44
Current: 77.03
57.16
77.44
Days Sales Outstanding 49.40
HCA's Days Sales Outstanding is ranked lower than
60% of the 220 Companies
in the Global Medical Care industry.

( Industry Median: 41.13 vs. HCA: 49.40 )
Ranked among companies with meaningful Days Sales Outstanding only.
HCA' s Days Sales Outstanding Range Over the Past 10 Years
Min: 44.84  Med: 52.29 Max: 56.3
Current: 49.4
44.84
56.3
Days Payable 116.17
HCA's Days Payable is ranked higher than
76% of the 164 Companies
in the Global Medical Care industry.

( Industry Median: 45.04 vs. HCA: 116.17 )
Ranked among companies with meaningful Days Payable only.
HCA' s Days Payable Range Over the Past 10 Years
Min: 108.24  Med: 112.98 Max: 122.04
Current: 116.17
108.24
122.04

Buy Back

vs
industry
vs
history
5-Year Yield-on-Cost % 0.30
HCA's 5-Year Yield-on-Cost % is ranked lower than
97% of the 316 Companies
in the Global Medical Care industry.

( Industry Median: 2.40 vs. HCA: 0.30 )
Ranked among companies with meaningful 5-Year Yield-on-Cost % only.
HCA' s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 0  Med: 0 Max: 0
Current: 0.3
3-Year Average Share Buyback Ratio 5.50
HCA's 3-Year Average Share Buyback Ratio is ranked higher than
96% of the 141 Companies
in the Global Medical Care industry.

( Industry Median: -2.40 vs. HCA: 5.50 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
HCA' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -202.3  Med: 0.95 Max: 12
Current: 5.5
-202.3
12

Valuation & Return

vs
industry
vs
history
Price-to-Intrinsic-Value-Projected-FCF 1.35
HCA's Price-to-Intrinsic-Value-Projected-FCF is ranked higher than
71% of the 98 Companies
in the Global Medical Care industry.

( Industry Median: 1.95 vs. HCA: 1.35 )
Ranked among companies with meaningful Price-to-Intrinsic-Value-Projected-FCF only.
HCA' s Price-to-Intrinsic-Value-Projected-FCF Range Over the Past 10 Years
Min: 1.26  Med: 3.6 Max: 29.58
Current: 1.35
1.26
29.58
Price-to-Median-PS-Value 1.16
HCA's Price-to-Median-PS-Value is ranked lower than
57% of the 230 Companies
in the Global Medical Care industry.

( Industry Median: 1.06 vs. HCA: 1.16 )
Ranked among companies with meaningful Price-to-Median-PS-Value only.
HCA' s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.52  Med: 1.01 Max: 1.5
Current: 1.16
0.52
1.5
Price-to-Peter-Lynch-Fair-Value 1.61
HCA's Price-to-Peter-Lynch-Fair-Value is ranked higher than
60% of the 57 Companies
in the Global Medical Care industry.

( Industry Median: 2.10 vs. HCA: 1.61 )
Ranked among companies with meaningful Price-to-Peter-Lynch-Fair-Value only.
HCA' s Price-to-Peter-Lynch-Fair-Value Range Over the Past 10 Years
Min: 0.68  Med: 1.9 Max: 3.67
Current: 1.61
0.68
3.67
Earnings Yield (Greenblatt) % 10.11
HCA's Earnings Yield (Greenblatt) % is ranked higher than
90% of the 270 Companies
in the Global Medical Care industry.

( Industry Median: 3.82 vs. HCA: 10.11 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) % only.
HCA' s Earnings Yield (Greenblatt) % Range Over the Past 10 Years
Min: 8  Med: 9.4 Max: 16
Current: 10.11
8
16
Forward Rate of Return (Yacktman) % 13.62
HCA's Forward Rate of Return (Yacktman) % is ranked higher than
59% of the 128 Companies
in the Global Medical Care industry.

( Industry Median: 10.40 vs. HCA: 13.62 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) % only.
HCA' s Forward Rate of Return (Yacktman) % Range Over the Past 10 Years
Min: 9.2  Med: 13.2 Max: 18.4
Current: 13.62
9.2
18.4

More Statistics

Revenue (TTM) (Mil) $41,853.00
EPS (TTM) $ 7.35
Beta0.13
Short Percentage of Float4.10%
52-Week Range $67.00 - 91.03
Shares Outstanding (Mil)366.90

Analyst Estimate

Dec17 Dec18 Dec19
Revenue (Mil $) 45,153 47,298 49,655
EPS ($) 7.38 8.01 8.68
EPS without NRI ($) 7.38 8.01 8.68
EPS Growth Rate
(Future 3Y To 5Y Estimate)
10.94%
Dividends per Share ($)
» More Articles for HCA

Headlines

Articles On GuruFocus.com
Annaly Capital Management: Attractive 9.5% Dividend Yield, but Interest Rates Are a Major Risk Jun 25 2017 
Never a Better Time to Pile on Chipotle Jun 25 2017 
Boeing Takes Lead Over Airbus With $30 Billion Worth of Orders on Day 1 of Paris Air Show Jun 25 2017 
Berkshire Hathaway’s Recent Investment: Home Capital Group Jun 25 2017 
Stocks That Fell to 3-Year Lows in the Week of June 23 Jun 24 2017 
Weekly Top Insider Buys Highlight for the Week of June 23 Jun 24 2017 
ID Watchdog Announces Special and Annual General Meeting Date and Record Date Jun 23 2017 
Ironclad Performance Wear Postpones 2017 Annual Meeting of Stockholders Jun 23 2017 
Delta and Korean Air Create Leading trans-Pacific Joint Venture Jun 23 2017 
Harwood Feffer LLP Announces Investigation of EnerNOC, Inc. Jun 23 2017 

More From Other Websites
CBO Deals A Blow To Senate's TrumpCare Bill, Imperils Moderate Support Jun 26 2017
Trading the CBO: 6 buys in healthcare Jun 26 2017
HCA Healthcare Presents 2016 HCA Healthcare Awards of Distinction Jun 26 2017
Top Research Reports for United Technologies, Intel & Kraft Heinz Jun 26 2017
Cramer: Soaring hospital stocks tell me the GOP Senate health bill won't pass Jun 23 2017
Cramer doesn't think GOP health-care bill will pass. Here... Jun 23 2017
The verdict on Trumpcare: A phenomenal waste of time Jun 23 2017
Senate Republicans unveil Obamacare replacement bill, but fate uncertain Jun 22 2017
Senate Republicans unveil Obamacare replacement bill, fate uncertain Jun 22 2017
Should Value Investors Pick HCA Healthcare (HCA) Stock Now? Jun 20 2017
ETFs with exposure to HCA Healthcare, Inc. : June 19, 2017 Jun 19 2017
HCA Healthcare, Inc. breached its 50 day moving average in a Bullish Manner : HCA-US : June 13, 2017 Jun 13 2017
Aventura Hospital seeks approval for major expansion Jun 12 2017
HCA Healthcare, Inc. -- Moody's rates HCA's secured notes offering Ba1; changes outlook to positive Jun 08 2017
HCA Announces Proposed Public Offering of Senior Secured Notes Jun 08 2017
Steel, chips, planes & more in the blitz Jun 07 2017
HCA Healthcare, Inc. :HCA-US: Earnings Analysis: Q1, 2017 By the Numbers : June 6, 2017 Jun 06 2017
Healthcare Sector Updates for May 22–26, 2017 May 31 2017
Analysis: Don't Look For The CBO Scoring To Keep AHCA Bill Off Trump's Desk May 26 2017

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}